The Influence of AI in Pharma Marketing
How is AI transforming pharmaceutical marketing?
AI is transforming pharmaceutical marketing by supporting a wide range of activities, from content creation and research to data analysis, automation and predictive decision-making. Technologies such as machine learning, generative AI and predictive AI can help marketing teams identify patterns, streamline repetitive tasks and use data to make more informed decisions.
AI can help pharmaceutical and life sciences marketers better understand their audiences and deliver more targeted, relevant and customer-centric communications. By analysing behavioural data, engagement patterns and audience interests, AI can support improved segmentation, personalisation and customer journeys across channels including websites, email, social media and marketing automation platforms.
Despite the opportunities AI presents, human expertise remains essential in pharmaceutical marketing to ensure accuracy, context, trust and responsible use. AI-generated insights and content must be carefully reviewed, particularly when dealing with scientific information and regulated communications, while considerations such as data privacy, bias, misinformation and compliance will become increasingly important as AI adoption continues.
Artificial Intelligence (AI) has been evolving for decades, experiencing periods of significant excitement followed by periods of reduced investment and interest. From the foundational work of Alan Turing and John McCarthy to the so-called AI Winter of the 1970s through to the 1990s, the development of AI has been shaped by both technological progress and changing expectations.
Today, we are experiencing another significant period of growth. The rapid development of generative AI, machine learning and predictive technologies has moved AI from something largely associated with technology and data science into an increasingly important part of everyday business.
For pharmaceutical and life sciences marketers, however, the opportunities presented by AI need to be considered alongside the unique requirements of the industry. Marketing to healthcare professionals, pharmaceutical decision-makers, researchers and other specialist audiences requires accuracy, credibility and a strong understanding of the science. AI can help marketers work more efficiently and gain deeper insights, but it also introduces questions around data privacy, accuracy, ethics, compliance and human oversight.
So, how is AI influencing pharma marketing, and what could its role look like in the future?
AI Tools
One of the most obvious ways AI is influencing marketing is through the tools now available to marketers.
Traditionally, many marketing processes relied heavily on manual research, data analysis, CRM management and repetitive administrative tasks. While these processes remain important, AI-powered technologies are increasingly being integrated into the marketing toolkit, helping teams automate tasks, identify patterns and make more informed decisions.
Three areas that are particularly relevant are machine learning, generative AI and predictive AI.
Machine learning
Machine learning enables systems to identify patterns within data and improve their predictions based on the information available to them. Within marketing, this can be used to analyse customer behaviour, campaign performance and engagement data to identify trends that may not be immediately obvious to a human analyst.
For example, machine learning could help a marketing team understand which types of content generate the strongest engagement from different audience groups, or identify patterns in website behaviour that suggest a prospect is becoming more interested in a particular service.
However, the effectiveness of machine learning is dependent on the quality and suitability of the data it receives. In pharma and life sciences, this is particularly important given the sensitivity of much of the information involved and the importance of maintaining appropriate data privacy and governance.
Generative AI
Generative AI has arguably been the most visible development in AI over recent years. Tools such as ChatGPT can generate text, assist with research and brainstorming, summarise information and provide initial drafts for a wide variety of marketing activities.
For a pharma marketing team, this could mean using generative AI to develop an initial newsletter concept, brainstorm campaign themes, create alternative headlines, summarise a long piece of research or adapt content for different channels.
However, generative AI should be viewed as a starting point rather than a replacement for subject-matter expertise. AI-generated content can contain inaccuracies, omit important context or present information with more confidence than is warranted. In an industry where scientific accuracy and regulatory considerations are critical, every piece of AI-assisted content requires appropriate human review.
Predictive AI
Predictive AI uses techniques such as machine learning and deep learning to identify patterns and make predictions about future outcomes. In marketing, this can help teams identify potential trends, improve decision-making and understand which prospects or customers may be more likely to engage with a particular campaign.
Predictive technologies can also support lead scoring and prioritisation, helping sales and marketing teams focus their time and resources where they are most likely to have an impact. The challenge is that predictive models are only as reliable as the data and assumptions behind them. They can also require significant investment to implement and maintain effectively.
AI-powered chatbots are another increasingly common application. These can provide customers with 24/7 responses to common questions and enquiries while collecting useful information about customer preferences and behaviour such as location, usage and identifiers. This can allow customer service and marketing teams to focus on more complex, higher-value interactions. However, the technology should not simply be implemented because it’s available. If an audience strongly prefers human interaction, for example, you could opt to have the phone lines open for longer hours to meet the needs and expectations of your customers.
Enhancing Customer Insights
Understanding an audience has always been central to effective marketing. In pharmaceutical marketing, this becomes even more important because audiences can be highly specialised and their information needs can vary significantly. AI is providing marketers with new ways to analyse these audiences and gain a deeper understanding of how they interact with brands and content.
AI-driven sentiment analysis, for example, can help organisations assess how audiences are responding to particular topics, messages or campaigns. Behavioural models can also be used to identify patterns in engagement and help marketers understand which messages are most relevant to particular audiences and when they may be most effective.
Rather than relying exclusively on historical campaign reports, surveys or manually collected feedback, marketers can increasingly analyse behavioural data from digital interactions.
Consider a pharmaceutical or life sciences company publishing a technical article. AI-powered analysis could help identify which sections are attracting the most engagement, what related content a visitor subsequently explores, and which topics appear to be generating the greatest interest. These insights can then inform future content.
For social media, this might mean adapting the tone, length or format of posts depending on how different audience segments respond. For email marketing, it could influence subject lines, content selection, send times or follow-up journeys.
Over time, the continual analysis of audience behaviour can help marketing teams move away from a one-size-fits-all approach and towards more relevant, evidence-led communication.
Targeting and Segmentation
Audience segmentation is another area where AI has the potential to significantly enhance pharmaceutical marketing.
Traditional segmentation might involve grouping audiences according to job title, organisation, location, industry or other demographic characteristics. While these remain useful, AI can help marketers go further by considering behavioural signals and patterns of engagement. For example, AI could help identify groups of professionals who consistently engage with particular scientific topics, formats or services. Rather than simply knowing that someone is a senior pharmaceutical professional, marketers can begin to understand what that individual or organisation is actually interested in.
Natural Language Processing (NLP) is particularly relevant here. NLP enables computers to interpret and generate human language, creating opportunities for marketers to analyse large volumes of written information and understand themes, sentiment and intent.
This could help marketers tailor messaging to different audience segments, whether they are communicating with scientists, procurement teams, commercial decision-makers, manufacturing professionals or senior executives. For an industry where audiences are often highly specialised, this ability to deliver the right information to the right people is particularly valuable.
Integration with Marketing Deployment Tools
AI becomes even more powerful when it is integrated into the systems marketers already use. Modern marketing teams typically work across a range of platforms, including customer relationship management (CRM) systems, marketing automation platforms, analytics tools, email platforms and social media channels. Integrating AI across this marketing stack can help improve both efficiency and campaign performance.
For example, predictive models can support lead scoring by identifying prospects who are more likely to engage or convert. Marketing automation systems can use behavioural information to determine when follow-up communications should be delivered, while analytics platforms can help identify which campaigns and channels are producing the strongest results.
Instead of every member of an audience receiving exactly the same sequence of communications, campaigns can respond to individual behaviours. Someone who repeatedly engages with a particular subject may receive more relevant content, while someone who shows little interest can be moved into a different journey. The integration of these systems can also help reduce the gaps that can occur between different marketing platforms. By bringing data and insights together, teams can create a more consistent view of their audiences and provide a more connected experience across email, websites, social media and other channels.
Most importantly, automation should give marketers more time to focus on the areas where human expertise adds the greatest value: strategy, creativity, relationship building and decision-making.
The Shift Towards Customer-Centric Campaigns
Perhaps one of the most significant changes AI is driving is the move towards increasingly customer-centric marketing. Rather than starting with the question, ‘What do we want to say?’, marketers can increasingly start with, ‘What does our audience need?’ AI can help identify customer needs, interests and behaviours and use these insights to inform campaigns and customer journeys.
For example, a campaign could begin with educational content, followed by more detailed technical information for people who demonstrate a deeper interest. Subsequent communications could then be personalised according to the individual’s interactions. This creates a journey that is more responsive to the customer rather than relying on a fixed campaign structure.
The growing expectation for personalisation makes this particularly important. Salesforce’s State of Marketing research has highlighted the increasing adoption of both predictive and generative AI among marketers, demonstrating how quickly these technologies are becoming part of mainstream marketing activity. For pharma marketers, personalisation needs to be approached carefully. The objective should not simply be to create as much personalised content as possible, but to make communications more useful and relevant without compromising accuracy, privacy or trust.
When used appropriately, AI can help organisations better understand their audiences and anticipate their information needs. This can ultimately help companies build stronger relationships with healthcare professionals, researchers, commercial stakeholders and other audiences across the industry.
The Future of AI in Pharma Marketing
AI’s capabilities are likely to continue developing, with AI becoming increasingly embedded into the tools and platforms marketers already use. Content creation, data analysis, campaign optimisation, automation and personalisation are all likely to become more sophisticated. However, the future of AI in pharma marketing will not simply be about what the technology can do. It will also be about what it should do. Questions around misinformation, accuracy, bias, data protection, intellectual property and regulatory compliance will become increasingly important as AI becomes more deeply integrated into marketing activity.
This is particularly significant within the pharmaceutical and life sciences industries. Marketing communications can involve highly technical and scientific information, and inaccurate or misleading content can have consequences far beyond a poor-performing campaign. Human oversight will therefore remain essential.
Marketing professionals will need to understand not only how to use AI tools, but also their limitations. The most effective teams are unlikely to be those that simply use the most AI. Instead, they will be the teams that understand where AI can add genuine value and where human expertise is still essential. This will require marketers to develop a new set of skills. Understanding AI capabilities, asking effective prompts, evaluating AI-generated outputs, interpreting data and maintaining appropriate governance will become increasingly valuable alongside traditional marketing skills.
Final Thoughts
AI is already changing the way pharmaceutical and life sciences companies approach marketing. From improving efficiency and automating repetitive processes to generating customer insights, strengthening segmentation and supporting personalised campaigns, AI offers marketers significant opportunities to work smarter and communicate more effectively. But AI should not be viewed as a replacement for marketers.
The strongest approach is likely to be a combination of technology and human expertise. AI can process vast amounts of information, identify patterns and accelerate processes, while experienced marketers bring creativity, context, critical thinking, industry knowledge and an understanding of their audience. For pharmaceutical marketing in particular, that balance is crucial.
As AI continues to evolve, so must our understanding of how to use it. The opportunity for pharma marketers is not simply to adopt AI, but to use it to create more informed, relevant and customer-centric marketing, while maintaining the accuracy, trust and responsibility that the industry demands.
FAQs
What is the role of AI in pharmaceutical marketing?
AI can support pharmaceutical marketers by automating repetitive tasks, analysing large volumes of data, identifying audience behaviour patterns and helping to improve targeting, personalisation and campaign performance. AI can also support activities such as content ideation, research, lead scoring and marketing automation, although human expertise remains essential.
How can generative AI be used in pharma marketing?
Generative AI can help pharmaceutical marketing teams develop initial content ideas, brainstorm campaign themes, create alternative headlines, summarise research and adapt content for different marketing channels. However, AI-generated content should always be reviewed by appropriate subject-matter experts to ensure scientific accuracy, context and compliance.
How can AI improve audience targeting and segmentation in pharma marketing?
AI can analyse behavioural signals, engagement patterns and audience interests alongside more traditional segmentation criteria. This can help marketers better understand what different audiences are interested in and deliver more relevant content and communications to healthcare professionals, researchers, decision-makers and other specialist audiences.
Can AI help create more personalised pharmaceutical marketing campaigns?
Yes. AI can help analyse how individuals interact with content and use these insights to support more personalised customer journeys. For example, marketers can provide different content or follow-up communications based on an individual's interests and engagement. Personalisation, however, should remain useful and relevant while respecting privacy, accuracy and trust.
What are the main risks of using AI in pharmaceutical marketing?
The main risks include inaccurate or misleading information, bias, data privacy concerns, intellectual property issues and potential regulatory compliance challenges. Because pharmaceutical marketing can involve complex scientific and technical information, AI outputs should not be used without appropriate human review and governance.
Will AI replace pharmaceutical marketers?
AI is unlikely to replace the need for experienced pharmaceutical marketers. While AI can process information, identify patterns and automate certain tasks, human marketers provide creativity, strategic thinking, industry knowledge, scientific context and critical judgement. The most effective approach is likely to combine AI capabilities with human expertise.
What is the future of AI in pharma marketing?
AI is likely to become increasingly integrated into marketing platforms and processes, supporting areas such as content creation, data analysis, campaign optimisation, automation and personalisation. However, as AI becomes more widely used, issues including accuracy, misinformation, data protection, bias and regulatory compliance will become increasingly important.
Photo by Yucel Yilmaz on Adobe Stock.
